0000899243-17-006601.txt : 20170306
0000899243-17-006601.hdr.sgml : 20170306
20170306165906
ACCESSION NUMBER: 0000899243-17-006601
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170301
FILED AS OF DATE: 20170306
DATE AS OF CHANGE: 20170306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Plunkett Matthew
CENTRAL INDEX KEY: 0001557551
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28386
FILM NUMBER: 17668615
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-01
0
0000891293
CTI BIOPHARMA CORP
CTIC
0001557551
Plunkett Matthew
C/O CTI BIOPHARMA CORP.
3101 WESTERN AVENUE, SUITE 600
SEATTLE
WA
98121
1
1
0
0
EVP, Chief Business Officer
Employee Stock Option (Right to Buy)
4.33
2017-03-01
4
A
0
60000
0.00
A
2027-02-28
Common Stock
60000
60000
D
The option is scheduled to vest in six semi-annual installments over the three-year period following the grant date, subject to the reporting person's continued employment or service with the issuer through the applicable vesting date.
/s/ Louis A. Bianco, Attorney-in-fact for Matthew Plunkett
2017-03-06